Multimodality Management of “Borderline Resectable” Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience

BACKGROUND: Pancreatic neuroendocrine tumors (PanNETs) constitute approximately 3% of pancreatic neoplasms. Like patients with pancreatic ductal adenocarcinoma (PDAC), some of these patients present with “borderline resectable disease.” For these patients, an optimal treatment approach is lacking. W...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Control
Main Authors: Ambe, Chenwi M., Nguyen, Phuong, Centeno, Barbara A., Choi, Junsung, Strosberg, Jonathan, Kvols, Larry, Hodul, Pamela, Hoffe, Sarah, Malafa, Mokenge P.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937248/
https://ncbi.nlm.nih.gov/pubmed/28975822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1073274817729076
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados